Chembio Diagnostics and Takeda Pharmaceutical Company Enter Collaboration to Develop Point-of-Care Diagnostic Test

Ads

You May Also Like

Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study

Proof of concept study of sequential ONCOS-102 then pembrolizumab treatment in patients with advanced ...

XOMA Reports Second Quarter 2016 Achievements and Financial Results

BERKELEY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in ...

Vical Provides VL-2397 Updates at BIO International Convention

SAN DIEGO, May 31, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that ...